Vaping marijuana by teens doubles in last seven years, with potentially harmful consequences

Marijuana vaping by school-aged youth doubled between 2013 and 2020, a new study found, with reported use within the last 30 days rising seven-fold during the same time period. The study(https://jamanetwork.com/journals/jamapediatrics/fullarticle/2785376?guestAccessKey=4df985fe-e703-49cc-a46f-da461093574e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102521), published in JAMA Pediatrics, analyzed 17 studies conducted throughout Canada and the United States that involved nearly 200,000 adolescents. The study found that teens in their senior year of high school were most likely to be vaping marijuana compared to younger adolescents. In 2018, for example, one in three grade-12 students reported vaping weed.

The use of marijuana by teens — in any form — is concerning because weed affects the adolescent brain differently, according to the US Centers for Disease Control and Prevention.

“The teen brain is actively developing and often will not be fully developed until the mid 20s,” the CDC stated, adding that use during that time “can have permanent effects” such as poor coordination and damage to learning, memory, problem-solving skills, and the ability to pay attention.

To read the full article, click here: https://www.cnn.com/2021/10/25/health/marijuana-teen-vaping-wellness/index.html

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here (https://iasic1.org/library/). The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top